STAT3 and myeloid leukemia: In order to better dissect the role of IFN-γ-induced STAT3 activation in the upregulation of PD-1 ligands on myeloid leukemia cells, a small-molecule inhibitor of STAT3 pathway, namely stattic, was used35.